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Class I MHC molecules (including H2-D, -K, -L in the mouse and
HLA-A, -B, -C in humans) are comprised of a heavy (44 kDa)
chain (which is glycosylated and highly polymorphic) and a light
(12 kDa) non-polymorphic chain termed b2-microglobulin (b2m).
These two subunits assemble in the endoplasmic reticulum (ER) in
the presence of short antigenic peptides (mostly 9-mers) and with
the aid of molecular chaperones and cellular proteins including
calnexin, calreticulin and the TAP1:TAP2 (transporter associated
with antigen processing) complex. Distinct class I assemblies
interact with these cellular proteins through stages of biosynthesis
(Hansen and Lee, 1997). In humans, calnexin preferentially inter-
acts with b2m-free, unfolded heavy chains. Calreticulin and the
TAP complex bind to b2m-associated heavy chains and facilitate
the folding and peptide loading of the class I complex, which is
then transported to the cell surface for recognition by cytotoxic 
T-lymphocytes (CTLs) and natural killer (NK) cells. During trans-
port, the core glycosylated heavy chain undergoes maturation and
sialyc acid moieties are added at last in the Golgi compartment
(Hansen and Lee, 1997).
The b2m subunit has been shown to be essential for the correct
assembly, biosynthesis and transport to the cell surface of most
class I molecules (Fellous et al, 1977; Hansen and Lee, 1997).
More recently, however, using antibodies capable of discrimi-
nating different conformations of class I molecules, several murine
class I heavy chains, including Db, Ld and Kb molecules, have been
detected at low levels on the surface of normal as well as trans-
formed cells lacking the b2m subunit and/or the TAP complex
(Potter et al, 1984; Allen et al, 1986; Smith et al, 1993; Machold
et al, 1995). These heavy chains, ‘free’ of b2m, have been demon-
strated to be either ‘unfolded’ (Allen et al, 1986; Smith et al,
1993), or at least partially folded (Machold et al, 1995), and to
bear mature carbohydrates (Hansen et al, 1988; Machold et al,
1995). Biochemical and functional data in b2m knockout mice are
consistent with the idea that both Db- and Ld-free heavy chains
may retain some ability to bind (Smith et al, 1993) and present
(Lehmann-Grube et al, 1994; Cook et al, 1995) antigen even when
synthesized in the absence of b2m. In contrast, there is no evidence
that any of the more than 300 sequenced HLA-A and -B alleles
might be constitutively expressed on the cell surface of most
(Fellous et al, 1977; D’Urso et al, 1992; Gattoni-Celli et al, 1992;
Wang et al, 1993; Bicknell et al, 1994; Porgador et al, 1997)
b2m-defective cells of human origin.
It has been long known that heavy chains unable to bind b2m
and/or peptide (Elliott, 1991) are retained in early exocytic
compartments to be subsequently degraded (Degen and Williams,
1991; Rajagopalan and Brenner, 1994). However, the efficiency of
the retention and degradation mechanisms has been found to be
different in different class I molecules. For instance, murine H2-Db
(Allen et al, 1986), -Ld (Smith et al, 1993) and human HLA-C
(Neefjes and Ploegh, 1988) heavy chains display a low binding to
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Summary Recent investigations have shown that malignant transformation may down-regulate the expression of class I HLA molecules,
b2-microglobulin (b2m) and members of the antigen-processing machinery. In the present study, we HLA-genotyped and identified at a
biochemical level the three (HLA-A25, -B8, -Cw7) class I alleles expressed by the previously described [D’Urso CM et al (1992) J Clin Invest
87: 284–292] b2m-defective human melanoma FO-1 cell line and tested their ability to interact with calnexin, calreticulin and the TAP
(transporter associated with antigen processing) complex. All these alleles were found to bind calnexin, but not calreticulin or the poorly
expressed TAP complex, both in parental and b2m-transfected FO-1 cells, demonstrating a complex defect of class I expression in FO-1 cells.
In these conditions, Cw7 heavy chains interacted with calnexin more strongly than A25 and B8, and preferentially accumulated in the
endoplasmic reticulum, in both a calnexin-associated and a calnexin-free form. In addition, they could be transported to the cell surface at low
levels even in the absence of b2m, without undergoing terminal glycosylation. These results establish a parallel between HLA-C and the
murine Db and Ld molecules which have been found to be surface expressed and functional in b2m-defective cells. They also demonstrate
distinctive features of HLA-C molecules. We propose that the accumulation of several assembly intermediates of HLA-C might favour the
binding of peptide antigens not readily bound by HLA-A and -B molecules in neoplastic cells with suboptimal class I expression.
Keywords: HLA-C; b2-microglobulin; calnexin; calreticulin; TAP; melanoma
639
British Journal of Cancer (1999) 80(5/6), 639–649
© 1999 Cancer Research Campaign
Article no. bjoc.1998.0405
Received 14 April 1997
Revised 4 November 1998
Accepted 6 November 1998
Correspondence to: P Giacominib2m and have the longest reported half-lives as free heavy
chains.
It has been proposed that clones of neoplastic cells unable to
express one or more class I alleles might arise and be selected in
vivo, in the immunocompetent host, possibly because they are
provided with a distinctive ability to evade the immune surveil-
lance (Garrido et al, 1993). Thus, the biochemical characterization
of the various class I molecules in class I-defective cells bears
implications on the mechanisms by which the various immune
effectors control neoplastic cell growth.
In the present report, we have studied the conformation, intra-
cellular transport and expression of class I molecules in the
b2m-defective FO-1 melanoma cell line (D’Urso et al, 1992) and
its b2m transfectants. To this end, we have used monoclonal anti-
bodies detecting free and b2m-associated HLA-A, -B, -C heavy
chains and have taken advantage of a recently characterized
(Setini et al, 1996) monoclonal antibody, named L31. This anti-
body detects a distinctive conformation of the a1 domain a helix
surrounding the peptide binding groove of most HLA-C, and a few
HLA-B, alleles when free of b2m (Setini et al, 1996). We provide
evidence herein for a complex multifactorial defect impairing
class I expression in FO-1 cells, for a distinctive biosynthesis of
HLA-C molecules and for their ability to be expressed on the
surface of FO-1 cells even in the absence of b2m.
MATERIALS AND METHODS
Cell lines and nucleic acid biochemistry
The b2m-defective FO-1 melanoma cell line and its serological
HLA typing (A25, -B8) have been previously described (D’Urso
et al, 1992). The HLA-A, -B, -C genotype of FO-1 was assessed
by locus-specific polymerase chain reaction (PCR) amplification
of genomic DNA followed by second and third exon direct
sequencing, as described (Pera et al, 1997). The isoelectro-
focussing (IEF) pattern (Giacomini et al, 1997) and the HLA-A, -
B, -C genotype (Prasad and Yang, 1996) of the HLA homozygous
MGAR B-cell line have been published. The HLA-A, -B, -C nega-
tive 721.221 cell line (221 hereafter) (Shimizu and DeMars, 1989)
and its Cw*0102 transfectants (Setini et al, 1996), the
TAP1/TAP2-defective cell line 174 3 CEM.T2 (T2 hereafter) and
its parental counterpart T1 (Salter and Cresswell, 1986) have been
described. To increase the expression of TAP molecules, FO-1
cells were treated with recombinant interferon (IFN)-g at the
optimal concentration of 100 U ml21 for 72 h.
A full length cDNA for human b2m was obtained as described
(Martayan et al, 1997). The pCMV-b2m plasmid and the empty
pCMV–neo vectors (20 mg) were linearized with Xmn I and
transfected by lyposome-mediated DNA transfer (Boehringer
Mannheim, Germany). Stable transfectants were isolated on the
basis of their ability to grow in 750 mg ml21 G418 (Gibco BRL,
Gaithersburg, MD, USA). Individual colonies were recovered in
cloning cylinders and expanded.
Immunochemical methods
The following mouse monoclonal antibodies to class I molecules
were used: Namb-1 is to b2m (Pellegrino et al, 1982); W6/32 is to
conformed HLA class I molecules associated with b2m (Parham
et al, 1979); L31 identifies an epitope present on all the sero-
logically defined HLA-C (Cw1 through Cw7) and on certain
HLA-B heavy chains (including B8) after denaturation. Pulse-
chase studies have shown that the L31 epitope becomes ‘hidden’
upon assembly with b2m, this process being more efficient in
HLA-B than HLA-C heavy chains. HLA-A heavy chains are
essentially unreactive with L31 (Setini et al, 1996; Giacomini et al,
1997). HC-10 was raised against denatured HLA-B locus heavy
chains and cross-reacts with certain HLA-C and -A products
including B8 and A25 (Stam et al, 1986). A monoclonal antibody
to 72-kDa heat shock protein (Amersham, Little Chalfont, UK)
and rabbit polyclonal antibodies to the C-terminal sequences of
calnexin and calreticulin (Stressgen, Victoria, Canada) were also
used. The polyclonal antibodies to TAP1 and TAP2 were generous
gifts of Dr J Trowsdale. Flow cytometry, metabolic labelling and
one-dimensional IEF have been previously described (Yang, 1989;
Setini et al, 1996). Western blotting experiments were performed
as described (Setini et al, 1996) using chemiluminescence as a
detection method. Cell surface iodination was carried out by
Iodogen beads (Pierce, Rockford, IL, USA) in conditions reported
(Markwell and Fox, 1978) to limit the access of 125I to surface
structures. In certain control experiments, iodination was
performed on cell extracts. Cells were lysed by hypotonic shock in
10 mM sodium chloride, 5 mM magnesium chloride, 1 mM dithio-
threitol and 10 mM Tris pH 7.4, and disrupted by 20 strokes of a
Dounce homogenizer. The postnuclear supernatants were radio-
labelled in parallel with whole viable cells using the Iodogen
beads, then adjusted to 1% NP40 (final concentration) and
immunoprecipitated.
RESULTS
HLA-A, -B, -C genotyping of FO-1 cells
HLA-A and -B DNA fragments were PCR amplified from
genomic DNA of FO-1 cells and sequenced. The previously
defined HLA-A25 and -B8 specificities (D’Urso et al, 1992) were
found to correspond to the HLA-A*2501 and -B*0801 alleles.
HLA-C, for which no tissue typing is available, was genotyped as
HLA-Cw*0701. Hereafter, these alleles will be referred to as
HLA-A25, B8 and -Cw7. No other HLA-A, -B or -C specific
DNA fragments could be amplified from FO-1 cells.
Allele assignment of HLA-A, -B, -C heavy chain
components synthesized by FO-1 cells
To identify the three genotyped class I alleles at the protein level
and assess their biochemical features both in the presence and
absence of b2m, FO-1 cells were transfected with either the
pCMV-b2m or the empty pCMV–neo vector. Two G418-resistant
colonies of FO-1 cells from each transfection experiment were
metabolically labelled and immunoprecipitated with antibodies to
b2m-free and b2m-associated heavy chains. These preliminary
experiments identified two different patterns of antibody reac-
tivity, exclusively dependent on the presence or absence of b2m
(not shown). Because representative of the two patterns of anti-
body reactivity, parental (FO-1–PT) cells and one b2m1 transfec-
tant (FO-1–b2m) were selected to be employed in further
biochemical studies.
To distinguish the different class I heavy chains after immuno-
precipitation, we took advantage of one-dimensional IEF, a
conventional method to resolve the different HLA-A, -B, -C
alleles (Neefjes et al, 1986). FO-1 parental cells, their b2m
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1996) MGAR cell line (HLA-A*2601, -B*0801, Cw*0701; from
here on referred to as A26, B8 and Cw7) whose IEF pattern we
recently characterized (Giacomini et al, 1997) were metabolically
labelled for 2 h with 35S-methionine, solubilized by the non-ionic
detergent NP40 and immunoprecipitated with antibodies Namb-1
to  b2m, W6/32 to b2m-associated heavy chains and L31 to
b2m-free heavy chains. In order to reduce the charge heterogeneity
of class I heavy chains and characterize these molecules in their
sialylation (i.e. in their intracellular transport), class I immunopre-
cipitates were analysed by IEF both undigested and digested with
neuraminidase.
From the results presented in Figure 1, lanes 8–18, it may be
noted that MGAR and FO-1–b2m cells gave rise to remarkably
similar IEF patterns with all the antibodies used. This was
expected, since the two cell lines are HLA-B/-C identical and the
A25 and A26 alleles are known (Yang, 1989) to comigrate in IEF.
The B*0801 allele expressed by both FO-1–b2m and MGAR cells
had the limited pI heterogeneity of HLA-A and -B alleles and
migrated as 2 and 3 regularly spaced bands respectively (Figure 1,
lanes 8 and 17: arrowheads). Upon neuraminidase digestion only
the unsialylated, most basic band remained in both cells (Figure 1,
lanes 9 and 18), identifying the HLA-B*0801 polypeptides in the
two cell lines and demonstrating their identity. The remaining
bands in the low (acidic) region of the gel were assigned to HLA-
Cw*0701. In contrast to HLA-A and -B alleles (Hajek-Rosenmayr
et al, 1989; Setini et al, 1996), HLA-Cw7 displayed a multiplicity
of irregularly spaced bands, five of which (marked as Cw7 in
Free HLA-C heavy chains in HLA-A, -B, -C defective cells 641
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Figure 1 Immunochemical analysis of class I HLA molecules synthesized by FO-1 cells and their b2m transfectants. Parental FO-1 cells (FO1-PT), one clone
transfected with the pCMV–b2m plasmid (FO-1–b2m) and the MGAR B-lymphoid cell line, as indicated, were metabolically labelled for 2 h with 35S-methionine.
Soluble extracts prepared with the non-ionic detergent NP40 were immunoprecipitated with immunoadsorbents covalently linked to the following antibodies:
W6/32 to b2m-associated heavy chains, L31 to b2m-free heavy chains and Namb-1 to b2m, as indicated. Immunoadsorbents conjugated with immunoglobulins of
irrelevant specificity (2) were used as negative controls. Immunoprecipitates were analysed by IEF (bottom: acidic end) both undigested (2) and digested (1)
with neuraminidase. Neuraminidase-insensitive and -sensitive (s 5 sialylated) HLA-Cw7 forms are indicated. Asterisks (*) identify background bands, present in
the control immunoprecipitates. These bands are prominent in the absence of specific immunoprecipitates. Dots (•), open circles (l l), and arrowheads ( )
indicate the HLA-A25, HLA-A26 and HLA-B8 components respectively. HLA-A25 heavy chains in FO-1–b2m cells display one acidic band which is not present in
the A26 heavy chains expressed by MGAR cells (see for instance lanes 12 and 17)
s
FO-1–PT FO-1–b2m MGARFigure 1) were (a) reactive with both W6/32 and L31, (b) insensi-
tive to neuraminidase and (c) present in parental FO-1 (Figure 1,
lanes 4–5) and FO-1–b2m (Figure 1, lanes 8–11) cells. With the
possible exception of the fourth band from the top, they were also
present in MGAR cells (Figure 1, lanes 15–16). Their preferential
reactivity with the HLA-C restricted L31 antibody, especially in
FO-1 cells (Figure 1, lanes 4–5 and 10–11), supports their assign-
ment to HLA-Cw7. It should be noted that some of these bands
(i.e. the second and third from the top) closely migrate and are not
fully resolved in certain IEF gels (see below). FO-1–b2m and
MGAR cells displayed all or most of the five Cw*0701 bands seen
in the parental FO-1 cells as well as two acidic and neuraminidase-
sensitive bands (marked as ‘s’) which were not seen in parental
FO-1 cells (compare lanes 8–11 and 15–16 to lanes 4–5).
Biochemical features of HLA-A, -B, -C molecules
synthesized by FO-1 cells
Immunoprecipitation with Namb-1 (and other antibodies to b2m,
not shown) demonstrated the presence of b2m in b2m transfectants
(Figure 1, lanes 12–13) and confirmed its absence in parental cells
(Figure 1, lanes 6–7). Similarly, the W6/32 antibody, known to
react with class I heavy chains only when complexed with b2m
(Parham et al, 1979), gave specific immunoprecipitates in the b2m
transfectants (Figure 1, lanes 8–9) but not in the b2m-negative
cells (Figure 1, lanes 2–3).
In addition to the classical uppermost b2m component, one
additional b2m band could be seen in Namb-1 and W6/32
immunoprecipitates from all the b2m-positive cells (Figure 1,
lanes 8–9, 12–13, 17–18). Because this additional component is
present in MGAR cells (Figure 1) and in wild-type cell lines of
B-lymphoid or neoplastic origin (Setini et al, 1996; Giacomini
et al, 1997), it does not represent an artifact resulting from plasmid
construction or transfection. The nature of this component was not
further investigated.
The levels of the b2m components greatly exceeded those of the
heavy chain when directly immunoprecipitated by the Namb-1
antibody to b2m (Figure 1, lanes 12–13), but not when co-precipi-
tated by the W6/32 antibody which recognizes heavy chains and
b2m in a defined (presumably 1:1) stoichiometric relationship
(Figure 1, lanes 8–9), suggesting the presence of a large excess of
free b2m in b2m transfectants. This excess was estimated to be ten
to 20-fold by densitometry. Noticeably, HLA-B8 heavy chains
were much less reactive with L31 in FO-1–b2m (Figure 1, lanes 4,
5, 10, 11) than MGAR (Figure 1, lanes 15–16) cells.
From the above data, we may conclude that: (a) transfection of
the b2m cDNA rescued the expression of W6/32-reacting class I
molecules in FO-1 cells; (b) HLA genotyping and protein
biochemistry concordantly identified the HLA-A25, -B8 and -
Cw7 alleles in FO-1 cells and each of the major class I heavy chain
components could be assigned to an individual class I allele; (c)
HLA-A, -B, -C alleles were sialylated only in the presence of b2m;
and (d) large amounts of HLA-Cw7 heavy chains were unable to
assemble with b2m. Presumably because not readily degraded,
they accumulated in a free heavy chain form in FO-1 as well as in
FO-1–b2m cells. This occurred even in the presence of a large stoi-
chiometric excess of b2m. In contrast, HLA-B8 did not signifi-
cantly accumulate in a free heavy chain form, suggesting that it
was more efficiently assembled and/or disposed than Cw7. A
practical consequence was that L31 behaved as an operationally
HLA-C-specific antibody in metabolically labelled FO-1 cells.
Steady-state levels of class I HLA molecules in FO-1
melanoma cells and their b2m transfectants
Next we wanted to determine whether the accumulation of free
HLA-Cw7 heavy chains could be explained by a preferential
ability of these molecules to interact with calnexin, calreticulin
and the TAP complex, thus accounting for their stability.
As a preliminary step to the assessment of protein:protein inter-
actions, the steady-state levels of class I heavy chains, calnexin,
calreticulin, TAP1 and TAP2 molecules were measured in total
cell extracts of parental FO-1 and FO-1–b2m cells. Soluble NP40
extracts were prepared, denatured in the presence of sodium
dodecyl sulphate (SDS), boiled, resolved by SDS-polyacrylamide
gel electrophoresis (SDS-PAGE), transferred to nitrocellulose
filters and blotted with specific antibodies, as described in the
legend to Figure 2. The HLA-A, -B, -C negative/b2m-positive 221
B cell line, FO-1 cells treated with IFN-g, the TAP1/TAP2-
negative T2 cell line, and its parental counterpart T1, were run as
controls. As shown in Figure 2A, the steady-state levels of the
L31-reactive class I heavy chains in FO-1 cells (L31 binds both
Cw7 and B8 after heavy chain denaturation, see Materials and
Methods) were slightly greater in the presence than in the absence
of b2m (possibly a result of the greater stability of heavy chain:
b2m complexes as compared to free heavy chains, see below), and
in the presence than in the absence of IFN-g (Figure 2, lanes 1–4).
However, they remained invariably much lower than in the
HLA-A, -B, -C expressing lymphoid cell lines (Figure 2, lanes
6–7). Interestingly, while calnexin (Figure 2, lanes 15–21) and
calreticulin (Figure 2, lanes 22–28) were expressed at similar
levels in all the cell lines, the TAP1 (Figure 2, lanes 8–14) and
TAP2 (not shown) subunits were expressed at much lower levels
in melanoma than in lymphoid cells. In Figure 2, they were
detectable after treatment with IFN-g or, in untreated cells, after
long exposures of the filter (Figure 2, lanes 8 and 10). In agree-
ment with the results presented in Figure 1, b2m was not a limiting
factor in class I assembly since it was present in comparable
amounts in all the b2m-positive cells (Figure 2, lanes 31–35). The
FO-1 melanoma cells and the control lymphoid cell lines therefore
express the two promiscuous chaperones calnexin and calreticulin
at similar high levels, while FO-1 cells selectively lack the class
I-dedicated chaperone (Solheim et al, 1997a), TAP.
Interactions of class I heavy chains with proteins of the
antigen processing machinery
It has been previously shown that calnexin binds b2m-free class I
heavy chains in parental FO-1 cells (Rajagopalan and Brenner,
1994). However, the effect of transfection with b2m on this inter-
action has not been assessed. Also unknown are the relative
abilities of the different heavy chain alleles to bind calnexin,
calreticulin and, in FO-1 cells, TAP. To address these issues,
soluble cell extracts were prepared in the mild non-ionic detergent
CHAPS, known to preserve protein:protein interactions. We found
CHAPS to be superior to digitonin in preliminary experiments.
CHAPS extracts from FO-1 and FO-1–b2m cells were immunopre-
cipitated with antibodies to TAP1, calnexin and calreticulin. The
resulting immunoprecipitates were run on a SDS-PAGE gel and
Western blotted. The filters were stained with antibodies to class I
heavy chains and with control antibodies. Parental 221 cells and
the 221.Cw*0102 transfectant were included as controls. It was
readily evident from this experiment (Figure 2 B–D) that class I
642 A Martayan et al
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FO-1 cells but also, although to a lesser extent, in FO-1–b2m cells
(Figure 2C, lanes 60–61). In both cases these interactions involved
the b2m-free heavy chains, as assessed by the absence of staining
with an antibody to b2m in the same filter (Figure 2, lanes 76–77).
In sharp contrast, essentially no HLA-A25, B8 and Cw7 heavy
chains were detectable, using two distinct antibodies to class I
molecules (see Materials and Methods for antibody specificities),
in association with either TAP1 (Figure 2, lanes 36–37, 44–45) or
calreticulin (Figure 2, lanes 84–85 and data not shown). This was
not unexpected in the case of the TAP complex, which was
expressed at low and practically undetectable steady-state levels
(see Figure 2, lanes 52 and 53 as compared to lanes 54 and 55; also
see lanes 8 and 10), but was quite surprising in the case of the high
abundance protein calreticulin (Figure 2, lanes 92–93). The proce-
dure we used to detect protein:protein interactions was sufficiently
sensitive, since calreticulin was found to associate with HLA-Cw1
heavy chains in 221.Cw1 cells (Figure 2, lane 87) and with b2m, as
described (Solheim et al, 1997b), in the HLA-A, -B, -C negative
221 cells (Figure 2, lane 102). Thus, the poor association of calreti-
culin with class I heavy chains was not due to technical reasons.
Co-immunoprecipitation experiments from metabolically labelled
cell extracts (not shown) confirmed that A25, B8 and Cw7 heavy
chains are unable to bind calreticulin.
From these data we may conclude that, even after reconstitution
with b2m, class I molecules are synthesized in FO-1 cells in the
presence of limiting amounts of the TAP complex. In addition,
they fail to efficiently interact with the high abundance calreticulin
protein. This indicates that the defect in class I expression of FO-1
cells is more complex than expected. In line with this interpreta-
tion, flow cytometry reproducibly (three separate experiments)
demonstrated that the W6/32-reactive molecules present at the
cell surface of FO-1–b2m cells cultured at 268C for 18 h were
from 25% to 50% more abundant than those in cells cultured at
378C (not shown). Stabilization by hypothermia is a common
feature in cells unable to properly assemble class I complexes
(Elliott, 1997).
Because the only detectable interaction of class I molecules in
FO-1 cells is with calnexin, we sought to determine to what extent
the three class I alleles expressed in FO-1 cells interact with
this molecular chaperone and to assess the time course of these
interactions.
Pulse-chase analysis of FO-1 melanoma cells
The calnexin:heavy chain interaction was studied by a 5-min pulse
with 35S-methionine followed by variable periods of chase, up to
180 min (Figure 3). CHAPS lysates were immunoprecipitated
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Figure 2 HLA-class I molecules in FO-1 cells: steady-state levels and interactions with members of the antigen-processing machinery. Soluble extracts of the
FO-1-PT and FO-1–b2m melanoma cells, and of the 221, T2 and T1 lymphoid cell lines were prepared with the non-ionic detergent CHAPS. (A) A total of 100
mg of cell extract per lane were submitted to SDS-PAGE (12.5% acrylamide, reducing conditions) and blotted onto a nitrocellulose filter. The filter was
stained/stripped five consecutive times with the indicated antibodies. The relevant areas of the filter displaying specific signals are shown. In the remaining
panels, the same extracts were immunoprecipitated by polyclonal rabbit antibodies to TAP1 (B), calnexin (C) and calreticulin (D), and, as a control, by normal
rabbit serum (NRS, B–D). Immunoprecipitates were resolved by SDS-PAGE (12.5%) and Western blotted. The resulting filters were stained with the indicated
antibodies. Bands of the expected sizes were identified by the various antibodies in selected areas of the filters644 A Martayan et al
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Figure 3 Pulse chase analysis of FO-1-PT and FO-1–b2m cells. The FO-1–PT and FO-1–b2m melanoma cells were pulsed for 5 min with 35S-methionine
(approximately 17.5 MBq ml21), then chased for the indicated times and lysed by the non-ionic detergent CHAPS. In (A) the soluble extracts were
immunoprecipitated with the L31 murine monoclonal antibody and a polyclonal antibody to calnexin. The resulting immunoprecipitates were resolved by IEF. A
control immunoprecipitate with the W6/32 antibody is also shown (for further details see the legend to Figure 1); in (B) the immunoprecipitates were prepared
with the L31 and W6/32 monoclonal antibodies and resolved by SDS-PAGE (12.5% acrylamide, reducing conditions). To monitor the intracellular transport of
class I molecules, immunoprecipitates were prepared in duplicate and either treated (1) by endoglycosidase H (Endo H) which cleaves immature glycans or
mock-treated (–). Bars in lanes 26 and 28 measure the distance of the class I heavy chains from a background band present in most lanes. The
autoradiography of the gel shown in lanes 18–25 lasted longer (72 h) than those of the gels depicted in the remaining lanes (24 h)
FO-1–b2m FO-1–PTwith L31 and with an antibody to calnexin, then analysed by IEF
(Figure 3A) and/or SDS-PAGE (Figure 3B) gels.
From the results shown in Figure 3, it appears that calnexin
migrated to a basic pl, as experimentally determined for this
protein (see information on the Internet at http://expasy.hcuge.ch/)
and associated with a variety of protein bands in both parental
(Figure 3, lanes 5–8) and b2m-transfected (Figure 3, lanes 13–16)
FO-1 cells. The bands comigrating with Cw1 were much more
abundant than those corresponding to the A25 and B8 heavy
chains (Figure 3, lanes 5 and 13). In agreement with the data in
Figure 1, the HLA-Cw1 heavy chains were sialylated and acquired
endoglycosidase H (Endo H) resistance only in the presence of
b2m (Figure 3, compare lanes 9–12 to lanes 1–4, and lanes 18–25
to lanes 26–41). As expected, sialylation and acquisition of Endo
H resistance were simultaneous and coincided with a slight
increase in the apparent molecular weight of the Cw7 heavy
chains, clearly seen by comparing lane 26 to lane 28. These events
mark the export of class I molecules from the ER.
In b2m-expressing FO-1 melanoma cells, export from the ER
correlated, as expected, with the release of Cw7 heavy chains
from calnexin (Figure 3, lanes 9–16). In contrast, large amounts
of L31-reacting Cw7 heavy chains were present in the ER of
b2m-defective cells and remained at similar high levels throughout
the first 60 min of chase (Figure 3, lanes 1–3), well after the nearly
complete disappearance of the calnexin:heavy chain complexes
(Figure 3, lanes 5–7). Remarkably, b2m-free Cw7 heavy chains in
parental and b2m-transfected FO-1 cells, although bona fide
located in different subcellular compartments, were equally stable
(Figure 3, lanes 18–33). Both were significantly less stable than
the W6/32-reactive class I molecules (Figure 3, lanes 24–25 and
32–33 as compared to lanes 40–41).
Thus, it appears that the Cw7 heavy chains, as compared to the
A25 and B8 heavy chains, preferentially interact with calnexin
both in the presence and in the absence of b2m. Because of this
and/or because of their intrinsic stability, Cw7 heavy chains pref-
erentially accumulate in large amounts in the ER in the absence of
b2m.
We were puzzled by the stability of the Cw7-free heavy chains
and wondered whether they were all bound for disposal, or, similar
to HLA-Cw1 (Martayan et al, 1997) and certain murine class I
molecules (Potter et al, 1984; Allen et al, 1986; Smith et al, 1993;
Machold et al, 1995), at least a fraction of HLA-Cw7 molecules
could be expressed on the cell surface in the absence of b2m.
Surface expression of free heavy chains in the absence
of b2m
Both the flow cytometry results shown in Figure 4 and the surface
labelling experiments shown in Figure 5 documented the presence
of very low levels of L31-reacting molecules and the absence of
significant levels of W6/32-reacting molecules on the surface of
b2m-defective FO-1 cells. Flow cytometry demonstrated that the
levels of free heavy chains in parental FO-1 cells were approxi-
mately 40% of those in b2m transfectants (Figure 4). In agreement
with these data, metabolic labelling (Figure 5A) and cell surface
iodination experiments (Figure 5B) followed by SDS-PAGE
analysis demonstrated that the FO-1 parental cell line was capable
of synthesizing (Figure 5, lane 2) and expressing only low molec-
ular weight free heavy chains on its surface (Figure 5, lane 10). At
variance, the FO-1–b2m cell line synthesized and expressed two
types of free heavy chains. The former, although possibly less
abundant, was similar in size to the free heavy chains expressed by
the parental cells. The latter type had a molecular weight typical of
mature heavy chains (Figure 5, lanes 6 and 13). These results
suggest that the free HLA-Cw7 heavy chains expressed on the
surface of FO-1–b2m cells include those which reach the surface in
parental cells and an additional pool, presumably derived from the
dissociation of heavy chain: b2m complexes. No class I heavy
chains were detected (not shown) on the cell surface of b2m-
defective cells using the HC-10 antibody (Stam et al, 1986). This
confirms previous findings demonstrating (D’Urso et al, 1992)
that several antibodies to b2m-free heavy chains fail to detect class
I molecules on the cell surface of FO-1 cells.
To determine whether the iodinated L31-reacting HLA-Cw7
molecules were from the cell surface or from intracellular class I
molecules released or exposed by dead or damaged cells, the
experiment depicted in Figure 5C was carried out. In this experi-
ment, performed in parallel with those shown in panels A and B,
the FO-1 and FO-1–b2m cells were Dounce homogenized, and the
homogenates submitted to the iodination procedure in parallel with
live cells. An antibody to heat shock protein 72 (Hsp 72) was used
to immunoprecipitate this cytosolic protein from metabolically
labelled cells (Figure 5A, lanes 3 and 7), 125I-labelled cells
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Figure 4 Flow cytometry analysis of class I HLA molecules in FO-1
melanoma cells and their b2m transfectants. FO-1 melanoma cells defective
in b2m (lower panel) and their b2m transfectants (upper panel) were stained
with the indicated monoclonal antibodies and with an antibody of irrelevant
specificity (–) by indirect immunofluorescence. Cells were analysed in a
FACScan (Becton & Dickinson) flow cytometer(Figure 5B, lanes 8 and 11) and 125I-labelled Dounce homogenates
(Figure 5C, lanes 15 and 17). Hsp72 was similarly visualized in
metabolically labelled cells and in 125I-labelled cell homogenates
(Figure 5A and C, arrows) but not in the 125I-labelled intact cells
(Figure 5B). Given the large amounts of 125I-HSP72 recovered
from the homogenates, it may be concluded that the lysis of even a
small percentage of cells in the experiments shown in Figure 5B
would be revealed by the presence of a 125I-Hsp72 band. Thus, the
iodination procedure employed was specific for cell surface
proteins.
In agreement with the low molecular weight of free heavy
chains in b2m-defective cells, a surface iodination experiment
followed by immunoprecipitation and IEF (Figure 6D) showed
that L31 identified unsialylated HLA-Cw7 heavy chains in
parental FO-1 cells (Figure 6, lane 18) and mainly sialylated heavy
chains in b2m-transfected FO-1 cells (Figure 6, lane 21).
Immunoprecipitation with the W6/32 antibody demonstrated the
presence of sialylated HLA-A25, -B8 and Cw7 heavy chains on
the surface of b2m transfectants (Figure 6, lane 22) but not on that
of parental FO-1 cells (Figure 6, lane 19). The absence of unsialy-
lated (pre-Golgi) HLA-A25 and -B8 molecules in lane 22
(compare these patterns with those in Figure 1) further pointed to
the cell surface specificity of the iodination procedure we
employed. The W6/32-reactive HLA-A25 molecules were
expressed on the cell surface in greater amounts than the B8 and
Cw7 molecules.
DISCUSSION
In the present study, the FO-1 human malignant melanoma cell
line, previously found to be b2m-defective (D’Urso et al, 1992),
was HLA-genotyped and further characterized at a biochemical
level. Surprisingly, transfection with b2m did not result in the
complete correction of the defect in class I expression of FO-1
cells, suggesting the presence of additional defects in class I
expression/antigen processing.
One such defect was identified as the selective down-regulation
of the class I-dedicated TAP chaperone (Solheim et al, 1997a), as
opposed to the normal levels of the promiscuous chaperones,
calnexin and calreticulin. Due, at least in part, to the extremely
low TAP levels, the class I:TAP interaction was not efficient.
Consequently, heavy chain:b2m dimers were formed, but were
thermally unstable, a feature considered to be the hallmark of
defective peptide loading and incomplete assembly of class I
molecules (Elliott, 1997).
At variance from TAP, the steady-state levels of calreticulin
were normal in FO-1 cells, and b2m was present in excess amounts
646 A Martayan et al
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Figure 5 Surface radio-labelling with 125I of FO-1 cells and their b2m transfectants. Parental FO-1 cells and their b2m transfectants, as indicated, were either
metabolically labelled for 2 h with 35S-methionine (approximately 8.7 MBq ml21) (A) or extrinsically labelled with 125I (B and D), solubilized by NP40 and
immunoprecipitated with the indicated antibodies to class I molecules, an antibody to the 72 kDa heat shock protein (Hsp) and an antibody of irrelevant
specificity (–). Alternatively, the cells were Dounce homogenized as described in Materials and Methods, and the lysates iodinated in parallel with whole intact
cells (C). Undigested immunoprecipitates were analysed, under reducing conditions, by either a 12.5% reducing SDS-PAGE (A–C) or an IEF gel (D). An arrow
marks the Hsp72 band in lanes 3 and 7. The low molecular weight heavy chain forms are indicated (H). The basic (unsialylated) HLA-Cw7 forms in lane 18
and the sialylated bands in lane 22 are indicated as in Figure 1. Additional acidic bands are also present in lanes 21–22 (dots) which are barely visible in
the IEF gels shown in Figures 1 and 3. An asterisk, as in Figure 1, marks a background bandin FO-1–b2m transfectants. However, neither class I molecules nor
b2m were capable of efficient interactions with calreticulin. This
appears to be qualitatively different from most of the available
examples (Seliger et al, 1997) of defects in class I expression of
neoplastic cells, known to reflect a true down-regulation of
members of the antigen-processing machinery.
It might be argued that a limiting stoichiometry of the TAP
complex may adversely affect the class I:calreticulin interaction,
thereby providing a common denominator for the two defects.
However, this seems unlikely because the class I:b2m dimer binds
calreticulin before binding to the TAP complex in the currently
accepted model of class I assembly (Elliott, 1997). Moreover, class
I:calreticulin complexes have been shown to form normally in a
TAP-defective cell line (Sadasivan et al, 1996). Thus, the defects
impairing the interactions of class I heavy chains with TAP and
calreticulin are most likely distinct. At the present time, we do not
know if the poor association of class I molecules with calreticulin
is due to a defect in a component of the antigen-processing
machinery distal to calnexin. It is intriguing to speculate that FO-1
cells might lack tapasin, a recently described molecule which
participates in the assembly of class I molecules (Ortmann et al,
1997). A down-regulation of tapasin might increase the turnover
of TAP molecules, thus explaining the low steady-state levels of
TAP found in FO-1 cells. Further experiments are required to
address this issue.
Another putative defect of FO-1 cells may be the loss of one
HLA-A, -B, -C haplotype. Because no more than three classical
class I alleles could be PCR-amplified from genomic DNA, either
FO-1 cells were derived from a HLA-homozygous donor or they
lost one haplotype, retaining only a hemizygous set of HLA-A, -B,
-C molecules. Due to the high number of class I alleles present at
the population level, the latter possibility is more likely. Only
further investigations will clarify this issue.
Thus, excluding the putative haplotype loss, a minimum of three
defects hinders class I expression in FO-1 cells: the lack of b2m, a
low expression of TAP and a poor class I:calreticulin interaction.
This variety of defects further adds to the complexity of the events
which may impair antigen presentation in a given tumour cell line.
Specifically, our results show that different alleles are affected in
different ways by the same defect(s) in class I assembly. For
instance, the A25 allele is surface-expressed at higher levels than
the B8 and Cw7 alleles in FO-1–b2m cells. Although the number
of W6/32-reacting molecules on the cell surface may not neces-
sarily reflect the number of peptide-filled (functional) class I mole-
cules, our results suggest that allele- and locus-specific features of
the class I heavy chains may determine which class I molecules
withstand damage to the antigen-processing machinery. This may
ultimately affect the repertoire of the residual CTL and NK
responses against class I-defective tumour cells.
A detailed characterization of the defects affecting class I
processing in FO-1 cells was not attempted in the present study.
Nevertheless, FO-1 cells exemplify a deranged biosynthesis of
class I molecules. The lack or drastic reduction of some biologi-
cally relevant protein:protein interactions provides a clear back-
ground against which the preferential interaction of calnexin with
HLA-Cw7 can be viewed. It has been recently shown that certain
HLA-C alleles display a more selective peptide binding and a
stronger interaction with the TAP complex than certain HLA-A
and -B alleles. Retention in the ER by the TAP complex may then
account for the low surface expression of HLA-C:b2m complexes
(Neisig et al, 1998). We found that at least two additional forms of
HLA-C molecules are refractory to degradation in FO-1 cells and
preferentially accumulate in the ER: the former b2m-free but
complexed with calnexin; the latter free of both b2m and calnexin.
At least this latter form is consistently present in a variety of cells
and in normal and neoplastic tissues (Giacomini et al, 1997). A
coordinated expansion of three intercommunicating molecular
pools of heavy chains (calnexin-bound, calnexin-free and TAP-
bound heavy chains) in cells capable of supporting optimal class
I:chaperone interactions may have been selected during evolution
to retard the transport of HLA-C. Perhaps the long permanence
and accumulation of HLA-C in the ER may be considered an
adaptive mechanism to compensate for its selectivity in peptide
binding. In addition, or alternatively, the various HLA-C assembly
intermediates may represent a reservoir of class I molecules
awaiting peptide loading. If so, alternative ligands might be
rescued from cellular proteins which, for some reason, failed to
serve as ligand donors for HLA-A and -B class I molecules.
The complete loss of class I expression is quite rare in human
neoplasm, which frequently undergo less severe losses (Garrido et
al, 1993). There is evidence that b2m and/or antigenic peptides are
available in limiting amounts in a significant percentage of
melanoma cells (Wang et al, 1996). The considerable stability of
HLA-C polypeptides in b2m-defective FO-1 cells suggests that
HLA-C may be less affected than HLA-A and -B heavy chains by
imbalances in the three subunits of the class I HLA complex. Thus,
HLA-C, although selective in its ability to bind peptides and
expressed at low levels on the cell surface, may be an important
recognition element for immune effectors (both CTLs and NK
cells) in tumours which retain suboptimal class I expression levels.
Some biochemical features of HLA-Cw7 molecules in b2m-
defective cells (its lack of reactivity with antibodies to conformed
heavy chains and expression on the cell surface) are reminiscent of
murine H2–Db and –Ld molecules (Potter et al, 1984; Allen et al,
1986). This indicates that surface expression in the absence of b2m
is the prerogative of a group of class I alleles which is largely inde-
pendent of the animal species, cell lineage and culture conditions.
No free HLA-A, -B, -C heavy chains have been detected at the
surface of most b2m-defective cell lines described to date (Fellous
et al, 1977; D’Urso et al, 1992; Gattoni-Celli et al, 1992; Wang et
al, 1993; Bicknell et al, 1994; Porgador et al, 1997). In a recent
report (Wang et al, 1998) the surface expression of HC-10-
reacting,  b2m-free HLA-A25 and -B8 heavy chains was detected
in FO-1 cells. This, however, required treatment with IFN-a and
hypothermia. Our results complement the available information,
since they indicate that the constitutive surface expression of free
heavy chains in the absence of b2m is a distinctive feature of HLA-
C molecules which may be observed only in certain cell lines.
Accordingly, we recently observed similar low surface levels of
free HLA-Cw1 heavy chains in the b2m-defective KJ29 kidney
carcinoma cell line (Martayan et al, 1997), and of free HLA-Cw3
and -Cw6 heavy chains in the Burkitt’s lymphoma Daudi cell line
(our own unpublished results). Our data and the published litera-
ture on the subject suggest that the massive intracellular accumula-
tion of HLA-C molecules might have an important role in
facilitating this event. The surface expression of free heavy chains
may then be considered a result of the ‘escape’ from the ER of a
few unfolded molecules, i.e. an epiphenomenon of intracellular
accumulation whose importance must still be established.
We have been able to demonstrate that, differently from murine
heavy chains, essentially all the free HLA-Cw7 heavy chains
expressed on the surface of parental FO-1 cells are unsialylated
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together, are clearly indicative of an ‘immature’ oligosaccharide
processing and unorthodox intracellular transport. Thus, a limited
but significant transport to the cell surface occurs in the case of
free HLA-Cw7 heavy chains even when they do not complete two
basic maturation steps, i.e. assembly and terminal glycosylation.
Further studies are warranted to establish whether the glycosyla-
tion intermediates of HLA-Cw7 detected in this study have a
distinctive ability to negotiate the exocytic path and may also
trigger CTL and NK responses. In this regard, it should be recalled
that certain NK receptors have a carbohydrate recognition domain
(Long and Wagtmann, 1997).
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